Clonit

📍 Milano, Italy🗓 Founded 1987👥 21 employees💰 Last funded Jul 2022
Founded in 1987, Clonit srl was one of the first Italian companies operating in the field of biotechnology. Since the beginning, the company has worked to develop innovative and reliable analytical methods in the field of In Vitro diagnostics using molecular biology techinques. The systems are useful for human diagnostic with particular attention to the detection of viral, bacteria and protozoa infections, genetic mutations and oncological diseases. The scientific innovations were transferred into ready to use diagnostic kits that, for the operating user-friendliness and the quality, are optimal for routine diagnostic laboratories. Proprietary technology is covered by a number of International patents some of which have been higly innovative for the field, such as the invention related to a solid state PCR amplification mix using thermoregulated polymers. The standardization of internal quality control system and cross-checks in outer reference labs have made Clonit able to assure the highest standards of care and quality (ISO 9001:2008 and ISO13485:2004 Certified). The company is registered and authorized from the Italian Ministry of the Health for the production of Medical Diagnostic devices Clonit offers to its customers an unrivalled experience in molecular biology.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
1987
Founded
Investor geography1 country
Italy
1
Frequently asked questions
Who invested in Clonit?
Clonit has 1 investor on record on gritt.io.
When did Clonit last raise funding?
The most recent investment in Clonit recorded on gritt.io was in July 2022.
When was Clonit founded?
Clonit was founded in 1987.
What industry is Clonit in?
Clonit operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Clonit based?
Clonit is headquartered in Milano, Italy.